Proval: Medgend

Search instead for removal

Proval FDA Approved Drugs

ACETAMINOPHEN AND CODEINE PHOSPHATE [Acetaminophen^{C₈H₉NO₂} : Codeine Phosphate^{2C₁₈H₂₁NO₃H₂O2H₃O₄P}]

120mg/5ml : 12mg/5ml (oral solution)

300mg : 15mg (oral tablet)

300mg : 30mg (oral tablet)

300mg : 60mg (oral tablet)

Hi Tech Pharma^{Apr 26, 1996}
Mikart^{Oct 27, 1992}
Pharm Assoc^{Approved Prior To Jan 1, 1982}
Vintage Pharms^{Nov 10, 2011}
Wockhardt^{Approved Prior To Jan 1, 1982}
Aurolife Pharma Llc^{Apr 15, 2013}
Mallinckrodt Inc^{May 31, 2001}
Teva^{Mar 6, 1985}
Amneal Pharms Ny^{May 29, 2008}
Sun Pharm Inds Ltd^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CAPITAL AND CODEINE [Acetaminophen^{C₈H₉NO₂} : Codeine Phosphate^{2C₁₈H₂₁NO₃H₂O2H₃O₄P}]

120mg/5ml : 12mg/5ml (oral suspension)

Valeant Pharms Llc^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

THALOMID [Thalidomide^{C₁₃H₁₀N₂O₄}]

100mg (oral capsule)

150mg (oral capsule)

200mg (oral capsule)

Celgene^{Jan 17, 2003}

Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (enl).
Approval for marketing only under a special restriction program approved by fda called 'system for thalidomide education and prescribing safety' (s.t.e.p.s.).
Maintenance therapy for prevention and supression of the cutaneous manifestations of enl recurrence.
Method for delivering a drug to a patient in need of the drug, while avoiding the occurence of an adverse side effect known or suspected of being caused by said drug.
Treatment of cutaneous manifestations of erythema nodosum leprosum (enl) in connection with a special program approved by fda called 'system for thalidomide education and prescribing safety' (s.t.e.p.s.).
Treatment of male patient having a disease or condition responsive to a teratogenic drug.
Use in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma.
Use of thalidomide in combination with dexamethasone for the treatment of patients with newly diagnosed multiple myeloma.
Use of thalidomide in treatment of cutaneous manifestations of erythema nodosum leprosum (enl).
Use of thalidomide while preventing the exposure of a fetus or other contraindicated individual to thalidomide.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TYLENOL W/ CODEINE NO. 3 [Acetaminophen^{C₈H₉NO₂} : Codeine Phosphate^{2C₁₈H₂₁NO₃H₂O2H₃O₄P}]

300mg : 30mg (oral tablet)

Janssen Pharms^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TYLENOL W/ CODEINE NO. 4 [Acetaminophen^{C₈H₉NO₂} : Codeine Phosphate^{2C₁₈H₂₁NO₃H₂O2H₃O₄P}]

300mg : 60mg (oral tablet)

Janssen Pharms^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Proval FDA Approved Drugs